This is an exciting moment for me, and I would like to share it with you.
Over the past 5 years I have encountered many Australian life sciences entrepreneurs looking for capital and clinical partners on both sides of the Pacific. I think Australia has a lot of potential for healthcare technology commercialisation but only if we invest effectively and if our public markets are quality, efficient and informed. You can read the “thesis” about why I believe in this potential in the “About” section of this site, I will not repeat it here. My objective is simple – to provide an independent and reasonably informed opinion about what I think of our life sciences ecosystem, particularly the microcap stocks that are traded on the ASX. Government policy, venture capital movement and the accomplishments of Australian researchers will also feature because they are probably relevant to how the overall system evolves in the future.
I want to state clearly from the outset, this is not a crusade. My actions on this site are based on my intrinsic belief that Australia really can be a world-class life sciences cluster – meaning healthcare services and IT, medtech, biotech, pharmaceuticals and even really future-looking areas like nanomedicine. I will admit I am also a bit partial to the potential of agricultural biotechnology – our planet has a lot of mouths to feed and we have some very smart minds working in this area. But I also don’t have any tolerance for bullsh*t, and there are a lot of dubious claims being made that are not disclosed in the best interest of the public / public investors. I am willing to directly but appropriately query those claims and if you I agree, I would like to receive your support. If you disagree I would like your structured and constructive feedback as to why. This will hopefully become a discussion forum, where a collective voice creates value and not just my own.
I am also not a perfect authority (unsurprisingly). As an entrepreneur, I have experienced a lot of different aspects of this industry but I will inevitably get it wrong at some stage. If I do, I will correct it, and I am sure you will remind me with vengeance.
The name of this blog – “The Long Tail” – could have just as easily been coined the “Tall Tale”. Australia definitely has some companies that are nothing more than a good story, though we also do not have an international monopoly on poor quality firms. However it is the “long tail” of the ASX that I am really interested in, the micro-cap (nano-cap?) companies that have used the ASX effectively as an alternative to venture capital. As such you will probably will not see much coverage of CSL in this blog. I used to think an ultra small-cap public market was a dumb idea but increasingly I believe that the investment horizons for new healthcare technologies are a poor fit with private investing, especially in Australia. Therefore, if this web site can even do a small amount to inject enthusiasm and discussion around the state of the industry, then it will have achieved its goal of helping to put some momentum into changing the way we think about this sector.
Thanks for reading…